Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors.
Glatthar, R., Stojanovic, A., Troxler, T., Mattes, H., Mobitz, H., Beerli, R., Blanz, J., Gassmann, E., Druckes, P., Fendrich, G., Gutmann, S., Martiny-Baron, G., Spence, F., Hornfeld, J., Peel, J.E., Sparrer, H.(2016) J Med Chem 59: 7544-7560
- PubMed: 27502541 
- DOI: 10.1021/acs.jmedchem.6b00598
- Primary Citation of Related Structures:  
5IU2 - PubMed Abstract: 
Cancer Osaka thyroid (COT) kinase is an important regulator of pro-inflammatory cytokines in macrophages. Thus, pharmacologic inhibition of COT should be a valid approach to therapeutically intervene in the pathogenesis of macrophage-driven inflammatory ...